Literature DB >> 18786556

Indirubin-3'-oxime impairs mitochondrial oxidative phosphorylation and prevents mitochondrial permeability transition induction.

Ana T Varela1, Ana P Gomes, Anabela M Simões, João S Teodoro, Filipe V Duarte, Anabela P Rolo, Carlos M Palmeira.   

Abstract

Indirubin, a red colored 3,2'-bisindole isomer, is a component of Indigo naturalis and is an active ingredient used in traditional Chinese medicine for the treatment of chronic diseases. The family of indirubin derivatives, such as indirubin-3'-oxime, has been suggested for various therapeutic indications. However, potential toxic interactions such as indirubin effects on mitochondrial bioenergetics are still unknown. This study evaluated the action of indirubin-3'-oxime on the function of isolated rat liver mitochondria contributing to a better understanding of the biochemical mechanisms underlying the multiple effects of indirubin. Indirubin-3'-oxime incubated with isolated rat liver mitochondria, at concentrations above 10microM, significantly depresses the phosphorylation efficiency of mitochondria as inferred from the decrease in the respiratory control and ADP/O ratios, the perturbations in mitochondrial membrane potential and in the phosphorylative cycle induced by ADP. Furthermore, indirubin-3'-oxime at up to 25microM stimulates the rate of state 4 respiration and inhibits state 3 respiration. The increased lag phase of repolarization was associated with a direct inhibition of the mitochondrial ATPase. Indirubin-3'-oxime significantly inhibited the activity of complex II and IV thus explaining the decreased FCCP-stimulated mitochondrial respiration. Mitochondria pre-incubated with indirubin-3'-oxime exhibits decreased susceptibility to calcium-induced mitochondrial permeability transition. This work shows for the first time multiple effects of indirubin-3'-oxime on mitochondrial bioenergetics thus indicating a potential mechanism for indirubin-3'-oxime effects on cell function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18786556     DOI: 10.1016/j.taap.2008.08.005

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

1.  Application of a homogenous membrane potential assay to assess mitochondrial function.

Authors:  Srilatha Sakamuru; Xiao Li; Matias S Attene-Ramos; Ruili Huang; Jianming Lu; Louie Shou; Min Shen; Raymond R Tice; Christopher P Austin; Menghang Xia
Journal:  Physiol Genomics       Date:  2012-03-20       Impact factor: 3.107

2.  Cardiac specific deletion of N-methyl-d-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia.

Authors:  Neetu Tyagi; Jonathan C Vacek; Srikanth Givvimani; Utpal Sen; Suresh C Tyagi
Journal:  J Recept Signal Transduct Res       Date:  2010-04       Impact factor: 2.092

3.  Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis.

Authors:  Ana P Gomes; Filipe V Duarte; Patricia Nunes; Basil P Hubbard; João S Teodoro; Ana T Varela; John G Jones; David A Sinclair; Carlos M Palmeira; Anabela P Rolo
Journal:  Biochim Biophys Acta       Date:  2011-10-17

4.  Molecular dynamics study of the inhibitory effects of ChEMBL474807 on the enzymes GSK-3β and CDK-2.

Authors:  Przemysław Czeleń; Beata Szefler
Journal:  J Mol Model       Date:  2015-03-10       Impact factor: 1.810

5.  Increased aerobic glycolysis is important for the motility of activated VSMC and inhibited by indirubin-3'-monoxime.

Authors:  Elke H Heiss; Daniel Schachner; Maddalena Donati; Christoph S Grojer; Verena M Dirsch
Journal:  Vascul Pharmacol       Date:  2016-05-14       Impact factor: 5.773

6.  Energy crisis precedes global metabolic failure in a novel Caenorhabditis elegans Alzheimer Disease model.

Authors:  Sheng Fong; Emelyne Teo; Li Fang Ng; Ce-Belle Chen; Lakshmi Narayanan Lakshmanan; Sau Yee Tsoi; Philip Keith Moore; Takao Inoue; Barry Halliwell; Jan Gruber
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.